APRI Profile of Cirrhotic Patients with Positive HBsAg
Downloads
Introduction: Hepatitis B is a viral infection that has the potency to become chronic infection and cause serious complications such as liver cirrhosis and hepatocellular carcinoma. One of the tools in diagnosing hepatitis B or cirrhosis and predicting the prognosis is aspartate aminotransferase to platelet ratio index (APRI). The purpose of this study is to evaluate the profile of APRI among cirrhotic patients with positive hepatitis B surface antigen (HBsAg).
Method: This research was a descriptive observational study. The number of samples was 35 cirrhotic patients with positive HBsAg in RSUD Dr. Soetomo Surabaya from January-December 2017.
Results: The majority of cirrhotic patients had >1,5 APRI score (48,57%). The most prevalent APRI score in Child A patients for first classification was 0,5 – 1,5 (5,71%) while for second classification was 0,7 – 1,5 (5,71%). The most prevalent APRI score in Child B patients for first classification was 0,5 – 1,5 (17,14%) while for second classification was 0,7 – 1,5 (11,43%). Most of Child C patients had >1,5 APRI score (22,86%). The majority of malignant degeneration patients also had >1,5 APRI score (14,29%).
Conclusion: The majority of cirrhotic patients had >1,5 APRI score. In cirrhotic patients with Child A or B classification, the increase of APRI score was not as much as those with Child C or malignant degeneration classification.
Keywords: Hepatitis B, cirrhosis, liver, hepatocellular carcinoma, APRI
World Health Organization. Hepatitis B. 2017. Available from: URL: www.who.int/news-room/fact-sheets/detail/hepatitis-b
Kementerian Kesehatan Republik Indonesia. Sebagian Besar Kematian Akibat Hepatitis Virus Berhubungan dengan Hepatitis B dan C Kronis. 2016. Available from: URL: www.depkes.go.id/article/view/16042700001/sebagian-besar-kematian-akibat-hepatitis-virus-berhubungan-dengan-hepatitis-b-dan-c-kronis.html
Wai CT, Greenson JK & Fontana RJ. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518-526.
Mao W, Sun Q, Fan J, et al. AST to platelet ratio index predicts mortality in hospitalized patients with hepatitis B-related decompensated cirrhosis. Medicine. 2016;95(9):2946.
McCormick PA & Murphy KM. Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Baillières Best Practice and Research Clinical Gastroenterology. 2000;14:1009-1031.
Adinolfi LE, Giordano MG & Andreana A. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. British Journal of Haematology. 2001;113:590-595.
Okuda M, Li K & Beard MR. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002;122:366-375.
Kamimoto Y, Horiuchi S & Tanase S. Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells. Hepatology. 1985;5:367-375.
Juliana IM & Wibawa IDN. Korelasi antara derajat penyakit sirosis hati berdasarkan klasifikasi Child-Turcotte-Pugh dengan konsentrasi trombopoietin serum. Penyakit Dalam. 2008;9(1):23-35.
Zhao X, Li J, Wang J, et al. Vitamin D serum level is associated with Child–Pugh score and metabolic enzyme imbalances, but not viral load in chronic hepatitis B patients. Medicine. 2016;95(27):3926.
Giannini E. Liver enzyme alteration: a guide for clinicians. Canadian Medical Association Journal. 2005;172(3):367-379.
Kamimoto Y, Horiuchi S & Tanase S. Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells. Hepatology. 1985;5:367-375.
Lin ZH, Xin YN & Dong QJ. Performance of the aspartate aminotransferase to platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53:726-736.
George D. Correlation between APRI index, MELD score and Child-Pugh score in cirrhosis of liver. Journal of Medical Science and Clinical Research. 2018;6(5).
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).
